University of Manchester

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Jul 11, 2026

Recruiting

Culturally-adapted Cognitive-behavioural Therapy for Black Sub-Saharan African and Caribbean People Experiencing Psychosis: A Case Series

Jul 1, 2026

Completed

First in Human (FIH) Clinical Investigation of Safety and Feasibility of a Novel Graphene Micro-electrocorticography Array for Brain Mapping in Neuro-oncology

Earlier

Feb 9, 2026TrialGRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia

Sep 1, 2025TrialPositron Emission Tomography to Assess the Effect of Camzyos on Ischaemia in HOCM: PEACH Trial

Feb 9, 2022TrialOptimising Cardiovascular Health in Endometrial Cancer Survivors

Oct 7, 2021TrialJAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM

Sep 14, 2021TrialGranulocyte Transfusions After Umbilical Cord Blood Transplant

May 28, 2020TrialSCIL-1Ra in COVID-19 Feasibility & PK/PD

3 more events

Jan 7, 2020TrialGene Therapy with Modified Autologous Hematopoietic Stem Cells for Patients with Mucopolysaccharidosis Type IIIA

Oct 11, 2018TrialSC IL-1Ra in SAH - Phase III Trial (SCIL)

May 17, 2018TrialDoes Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)